TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12953047

Group type: EXPERIMENTAL
Intervention: Prednisone at a dose of 60 mg/m2/day for 6 weeks, followed by 40 mg/m2/48 h for at least another 6 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Deflazacort
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (2 mg/kg/day for at least 8 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Levamisole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alternate day therapy of prednisone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single and divided dosing of prednisone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Duration of relapse therapy
Number of subjects: 0
Study: 10922084

Group type: EXPERIMENTAL
Intervention: Dyspeptic patients (n=156)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Control patients (n=27)
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Dyspeptic patients with suspected pancreatic disease
Number of subjects: 183

Group type: COMPARATOR
Intervention: Control patients
Number of subjects: 183
Study: 8715742

Group type: EXPERIMENTAL
Intervention: Self-administration of medicines
Number of subjects: 0

Group type: COMPARATOR
Intervention: Previous studies on self-administration
Number of subjects: 0
Study: 1359317

Group type: EXPERIMENTAL
Intervention: Transcervical chorionic villus sampling (TC CVS)
Number of subjects: 3079

Group type: EXPERIMENTAL
Intervention: Transabdominal chorionic villus sampling (TA CVS)
Number of subjects: 3079

Group type: EXPERIMENTAL
Intervention: Amniocentesis (AC)
Number of subjects: 3079
Study: 3887543

Group type: EXPERIMENTAL
Intervention: Cimetidine 1 g/day for 21 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31562799

Group type: EXPERIMENTAL
Intervention: Niraparib
Number of subjects: 733

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 733
Study: 28860546

Group type: EXPERIMENTAL
Intervention: Remote blood glucose telemonitoring program with feedback
Number of subjects: 85

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 85
Study: 26382239

Group type: EXPERIMENTAL
Intervention: LPV (Lopinavir)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: DRV (Darunavir)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Gag mutations (V7I, G49D, R69Q, A120D, Q127K, N375S, I462S)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Major PI resistance mutation I84V
Number of subjects: 7
Study: 23904145

Group type: EXPERIMENTAL
Intervention: Adherence readiness program
Number of subjects: 60
Study: 21365164

Group type: EXPERIMENTAL
Intervention: High intake of total n-3 long chain fatty acids (Q4)
Number of subjects: 3294

Group type: EXPERIMENTAL
Intervention: High intake of eicosapentaenoic acid (Q4)
Number of subjects: 3294

Group type: EXPERIMENTAL
Intervention: High fish consumption (Q4)
Number of subjects: 3294
Study: 19810579

Group type: EXPERIMENTAL
Intervention: Yoga-based Deep Relaxation Technique (DRT) for 20 minutes
Number of subjects: 86

Group type: COMPARATOR
Intervention: Supine Rest (SR) for 20 minutes
Number of subjects: 86
Study: 16919573

Group type: EXPERIMENTAL
Intervention: Poststress left ventricular ejection fraction (EF) lower than 51%
Number of subjects: 6713

Group type: EXPERIMENTAL
Intervention: Poststress end-systolic volume (ESV) index greater than 27 mL/m2
Number of subjects: 6713

Group type: EXPERIMENTAL
Intervention: Poststress EF of 51% or greater
Number of subjects: 6713

Group type: EXPERIMENTAL
Intervention: Poststress ESV index of 27 mL/m2 or less
Number of subjects: 6713
Study: 16249982

Group type: EXPERIMENTAL
Intervention: Acustimulation using a portable transcutaneous electrical nerve stimulation device (Reliefband) attached 15 minutes before the procedure, turned on in 78 patients (Group 1)
Number of subjects: 327

Group type: COMPARATOR
Intervention: Device attached but not turned on (Group 2)
Number of subjects: 327

Group type: COMPARATOR
Intervention: Device attached to the Sham point (Group 3)
Number of subjects: 327

Group type: COMPARATOR
Intervention: No attachments (Group 4)
Number of subjects: 327
Study: 11156644

Group type: EXPERIMENTAL
Intervention: Botulinum toxin (BT) injection (20 U) and subsequent daily applications of isosorbide dinitrate (ID) (2.5 mg three times daily for three months)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Botulinum toxin (BT) injection only (20 U)
Number of subjects: 30
Study: 9736895

Group type: EXPERIMENTAL
Intervention: Examinations conducted by trained therapists
Number of subjects: 138

Group type: COMPARATOR
Intervention: Therapists trained in examination techniques
Number of subjects: 138
Study: 7507304

Group type: EXPERIMENTAL
Intervention: Aprotinin (2 x 10(6) KIU bolus followed by 5 x 10(5) KIU/h infusion until end of surgery
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 40
Study: 2895173

Group type: EXPERIMENTAL
Intervention: Early hypocaloric enteral feeding (PO)
Number of subjects: 19
Study: 31597670

Group type: EXPERIMENTAL
Intervention: Electronic sexual health module with tailored feedback (randomized for half of the participants)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Electronic sexual health module without tailored feedback
Number of subjects: 66
Study: 28667231

Group type: EXPERIMENTAL
Intervention: Educational video about OSA and CPAP therapy
Number of subjects: 212

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 212
Study: 26090880

Group type: EXPERIMENTAL
Intervention: Compressive stockings
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo stockings
Number of subjects: 40
Study: 23898909

Group type: COMPARATOR
Intervention: SSRIs
Number of subjects: 30

Group type: COMPARATOR
Intervention: SSRIs plus quetiapine
Number of subjects: 30
Study: 21999887

Group type: EXPERIMENTAL
Intervention: SQ-standardized grass allergy immunotherapy tablet (AIT)
Number of subjects: 812

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 812
Study: 20178207

Group type: EXPERIMENTAL
Intervention: Carbamide peroxide treatment for 14 days
Number of subjects: 24

Group type: COMPARATOR
Intervention: Artificial saliva (control)
Number of subjects: 24
Study: 16774090

Group type: EXPERIMENTAL
Intervention: Cycling training group (N=10)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (N=14)
Number of subjects: 24
Study: 15501704

Group type: EXPERIMENTAL
Intervention: Calcium and Vitamin D supplementation
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 10938220

Group type: EXPERIMENTAL
Intervention: behavioral counseling
Number of subjects: 505

Group type: COMPARATOR
Intervention: standard health promotion
Number of subjects: 505
Study: 9293346

Group type: COMPARATOR
Intervention: Treadmill training (TM; N = 8)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Cycle ergometer training (CY; N = 10)
Number of subjects: 26
Study: 8337172

Group type: EXPERIMENTAL
Intervention: CSG with coaching
Number of subjects: 64

Group type: COMPARATOR
Intervention: CSG without coaching
Number of subjects: 64

Group type: COMPARATOR
Intervention: No CSG
Number of subjects: 64
Study: 2440199

Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol sulfonate (Turisteron)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 0
Study: 27798291

Group type: EXPERIMENTAL
Intervention: Daily meal delivery (n = 139)
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Once weekly, frozen meal delivery (n = 106)
Number of subjects: 371

Group type: COMPARATOR
Intervention: Control group (waiting list, n = 126)
Number of subjects: 371
Study: 27648674

Group type: EXPERIMENTAL
Intervention: Double-bundle (DB) technique
Number of subjects: 50

Group type: COMPARATOR
Intervention: Single-bundle (SB) technique
Number of subjects: 50
Study: 24725445

Group type: EXPERIMENTAL
Intervention: Test product (300 mg irbesartan tablet)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Reference product (300 mg irbesartan tablet)
Number of subjects: 26
Study: 23734218

Group type: EXPERIMENTAL
Intervention: Folic acid (FA) 0.8 mg / B12 0.4 mg with and without 40 mg B6
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: B6 alone
Number of subjects: 183

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 183
Study: 20091404

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 143

Group type: COMPARATOR
Intervention: Active control
Number of subjects: 143

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 143
Study: 18823190

Group type: EXPERIMENTAL
Intervention: Experimental introduction to counseling program
Number of subjects: 400

Group type: COMPARATOR
Intervention: Standard-introduction to counseling program
Number of subjects: 400

Group type: COMPARATOR
Intervention: Information-control group
Number of subjects: 400

Group type: COMPARATOR
Intervention: No-information-control group
Number of subjects: 400
Study: 16177808

Group type: EXPERIMENTAL
Intervention: 5 mg THC
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 15052277

Group type: EXPERIMENTAL
Intervention: High-Intensity (HI) exercise (three times 30 min in an interval protocol (2.5 min 80/50% W(max)))
Number of subjects: 8

Group type: COMPARATOR
Intervention: Low-Intensity (LI) exercise (three times 60 min continuously at 38% W(max))
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Both HI and LI exercise protocols
Number of subjects: 8
Study: 10904461

Group type: EXPERIMENTAL
Intervention: Walking program targeted to expend 4.2 MJ/wk and diet counseling (walk-1 group)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Walking program of 8.4 MJ/wk and diet counseling (walk-2 group)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group with no increase in habitual exercise and counseling on diet and relapse prevention
Number of subjects: 82
Study: 9291340

Group type: EXPERIMENTAL
Intervention: Tenidap (120 mg) daily for 6 weeks
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 7686709

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP) 30 mg/kg i.v.
Number of subjects: 21

Group type: COMPARATOR
Intervention: Isotonic saline (control group)
Number of subjects: 21
Study: 2874983

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pentobarbital
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Carbromal
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Methaqualone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Flunitrazepam
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lormetazepam
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Triazolam
Number of subjects: 12
Study: 31821654

Group type: EXPERIMENTAL
Intervention: Group-based physiotherapy (n = 24)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard care (n = 26)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (Group-based physiotherapy and Standard care)
Number of subjects: 50
Study: 30583933

Group type: EXPERIMENTAL
Intervention: Personalized lifestyle intervention group (LIG)
Number of subjects: 799

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 799
Study: 28458123

Group type: EXPERIMENTAL
Intervention: Caseload midwifery
Number of subjects: 1748

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1748
Study: 25382740

Group type: EXPERIMENTAL
Intervention: Resistive vibration exercise
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Resistance exercise without vibration
Number of subjects: 24

Group type: COMPARATOR
Intervention: No exercise (control group)
Number of subjects: 24
Study: 24004640

Group type: EXPERIMENTAL
Intervention: Positive Reappraisal Coping Intervention (PRCI)
Number of subjects: 372

Group type: COMPARATOR
Intervention: PRCI Control group
Number of subjects: 372
Study: 20977390

Group type: EXPERIMENTAL
Intervention: Rice (BR)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sugar-sweetened fruit drink (SSD)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Orange juice
Number of subjects: 10

Group type: COMPARATOR
Intervention: Spaghetti
Number of subjects: 10
Study: 19060453

Group type: EXPERIMENTAL
Intervention: 24 weeks of training
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 24 weeks of detraining
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 12 weeks of retraining
Number of subjects: 13

Group type: COMPARATOR
Intervention: Detraining
Number of subjects: 13

Group type: COMPARATOR
Intervention: Retraining
Number of subjects: 13
Study: 17103487

Group type: EXPERIMENTAL
Intervention: 0.2 mg DiaPep277
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: 1.0 mg DiaPep277
Number of subjects: 99

Group type: COMPARATOR
Intervention: 2.5 mg DiaPep277
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 14699544

Group type: EXPERIMENTAL
Intervention: Dynamic proximal segment positioning by intraoperative sonography
Number of subjects: 30

Group type: COMPARATOR
Intervention: Splint and plate positioning
Number of subjects: 30
Study: 11706697

Group type: EXPERIMENTAL
Intervention: Immediate drain opening (n = 45)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Drains opened at 2 h (n = 31)
Number of subjects: 76
Study: 9371164

Group type: EXPERIMENTAL
Intervention: Prophylactic amiodarone
Number of subjects: 6553
Study: 8485271

Group type: EXPERIMENTAL
Intervention: Cisapride 10 mg q.d.s. for 12 weeks
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 3333512

Group type: EXPERIMENTAL
Intervention: Prophylactic cloxacillin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 30892290

Group type: EXPERIMENTAL
Intervention: Guided bone regeneration with dental implant placement (study group)
Number of subjects: 22

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 22
Study: 27737534

Group type: EXPERIMENTAL
Intervention: Gemcitabine/Cisplatin (GP) - Gemcitabine 1,250 mg/m2 on days 1 and 8, Cisplatin 75 mg/m2 on day 1 every 3 weeks
Number of subjects: 279

Group type: COMPARATOR
Intervention: Irinotecan/Cisplatin (IP) - Irinotecan 65 mg/m2 and Cisplatin 30 mg/m2 on days 1 and 8 every 3 weeks
Number of subjects: 279
Study: 24671388

Group type: EXPERIMENTAL
Intervention: Ketamine (1.0 mg/kg in 20 ml of normal saline)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ketamine-levobupivacaine (0.5 mg/kg of ketamine plus 50.0 mg of 0.25% levobupivacaine in 20 ml of normal saline)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (20 ml of intraarticular normal saline)
Number of subjects: 60
Study: 22688605

Group type: EXPERIMENTAL
Intervention: Electrical stimulation in obese participants before weight loss
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Electrical stimulation in obese participants after weight loss
Number of subjects: 31

Group type: COMPARATOR
Intervention: Electrical stimulation in nonobese participants
Number of subjects: 31
Study: 21777715

Group type: EXPERIMENTAL
Intervention: Armodafinil (250 mg/d)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 19734382

Group type: EXPERIMENTAL
Intervention: True acupuncture
Number of subjects: 41

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 41
Study: 16449110

Group type: EXPERIMENTAL
Intervention: Heated, 95% humidified CO2
Number of subjects: 89

Group type: COMPARATOR
Intervention: Heated, dry CO2
Number of subjects: 89
Study: 12509398

Group type: EXPERIMENTAL
Intervention: CEE+MPA-cyclic (daily CEE and MPA at 10 mg/day on days 1-12)
Number of subjects: 571

Group type: EXPERIMENTAL
Intervention: CEE+MPA-continuous (daily CEE and MPA at 2.5 mg/day)
Number of subjects: 571

Group type: EXPERIMENTAL
Intervention: CEE-MP (daily CEE and micronized progesterone at 200 mg/day on days 1-12)
Number of subjects: 571

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 571
Study: 11025235

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1) administered intravenously at up to 15 ng/kg/min for 72 hours after surgery
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo (isotonic saline) administered for the same duration
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo (isotonic saline)
Number of subjects: 39
Study: 8658340

Group type: EXPERIMENTAL
Intervention: Various treatments for eyelid dermatitis (specific treatments not detailed in the abstract)
Number of subjects: 0
Study: 1609246

Group type: EXPERIMENTAL
Intervention: Terodiline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 4096071

Group type: EXPERIMENTAL
Intervention: Intravenous streptokinase (IV)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Intracoronary streptokinase (IC)
Number of subjects: 200
Study: 31737686

Group type: EXPERIMENTAL
Intervention: Aerobic Training (AT)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 105
Study: 29772291

Group type: EXPERIMENTAL
Intervention: Watching television while exercising
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Listening to music while exercising
Number of subjects: 24

Group type: COMPARATOR
Intervention: Exercising with no other stimulus (control)
Number of subjects: 24
Study: 27411777

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) plus normal saline (NS)
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (NaHCO3) plus normal saline (NS)
Number of subjects: 257

Group type: COMPARATOR
Intervention: Normal saline (NS) alone
Number of subjects: 257
Study: 24067260

Group type: EXPERIMENTAL
Intervention: 30 mg/d THC
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 60 mg/d THC
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 120 mg/d THC
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (0 mg/d THC)
Number of subjects: 11
Study: 23059145

Group type: EXPERIMENTAL
Intervention: d‐cycloserine (50 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 20613539

Group type: EXPERIMENTAL
Intervention: Peritonsillar lornoxicam infiltration
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intravenous lornoxicam
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (i.v. and peritonsillar saline infiltration)
Number of subjects: 60
Study: 18410644

Group type: EXPERIMENTAL
Intervention: Incredible Years (IY) BASIC Parenting Programme
Number of subjects: 50

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 50
Study: 16025322

Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone 2/0.5 mg
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone 8/2 mg
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone 32/8 mg
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control group (recently detoxified participants, N=8)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone (all doses)
Number of subjects: 7
Study: 12411797

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 51

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 51
Study: 10499753

Group type: EXPERIMENTAL
Intervention: Clonidine 0.5 microg/kg intramuscularly and saline in the surgical site
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Clonidine 0.5 microg/kg in the surgical site and saline intramuscularly
Number of subjects: 45

Group type: COMPARATOR
Intervention: Saline in both the surgical site and intramuscularly (Control)
Number of subjects: 45
Study: 8891659

Group type: EXPERIMENTAL
Intervention: Memory-guided saccade task in schizophrenic patients
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Delayed-saccade task in schizophrenic patients
Number of subjects: 30

Group type: COMPARATOR
Intervention: Memory-guided saccade task in normal controls
Number of subjects: 30

Group type: COMPARATOR
Intervention: Delayed-saccade task in normal controls
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Final eye position after correction saccades in both groups
Number of subjects: 30
Study: 1502490

Group type: EXPERIMENTAL
Intervention: Bismuth subsalicylate (Pepto-Bismol) - 2 tablets four times daily for 4 weeks
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Bismuth subsalicylate combined with clindamycin - 2 weeks of 300 mg clindamycin four times daily
Number of subjects: 18
Study: 6497564

Group type: EXPERIMENTAL
Intervention: Haloperidol (5 mg test dose; 10 mg maintenance dose)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Thiothixene hydrochloride (0.22 mg/kg test dose; 0.44 mg/kg maintenance dose)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Haloperidol (5 mg test dose)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 100
Study: 31586371

Group type: EXPERIMENTAL
Intervention: NASM exercises with ergonomic intervention (12 weeks)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (no regular exercise)
Number of subjects: 23
Study: 29929990

Group type: EXPERIMENTAL
Intervention: Mandibular advancement device
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sham device
Number of subjects: 27
Study: 26966825

Group type: EXPERIMENTAL
Intervention: Maitland's Central postero-anterior vertebral pressure for thoracic spine (T1-T8) in addition to individualized treatment for low back pain and home exercise program (HEP) of breathing exercises
Number of subjects: 62

Group type: COMPARATOR
Intervention: Individualized treatment for low back pain and home exercise program (HEP) of breathing exercises
Number of subjects: 62
Study: 24986816

Group type: EXPERIMENTAL
Intervention: A1 beta-casein milk (750 ml/day)
Number of subjects: 41

Group type: COMPARATOR
Intervention: A2 beta-casein milk (750 ml/day)
Number of subjects: 41
Study: 22488220

Group type: EXPERIMENTAL
Intervention: Behavioral educational intervention
Number of subjects: 540

Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 540
Study: 20855362

Group type: EXPERIMENTAL
Intervention: Lasmiditan (2.5-45 mg)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Lasmiditan (20 mg and higher)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Lasmiditan
Number of subjects: 130
Study: 17618954

Group type: EXPERIMENTAL
Intervention: Slow-release metformin (SR)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Regular-release metformin (RR)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (not applicable)
Number of subjects: 55
Study: 15578245

Group type: EXPERIMENTAL
Intervention: Composite mesh with hydrophilic resorbable film
Number of subjects: 80